SKN | City Therapeutics Raises $200 Million in Upsized IPO at $18 per Share
City Therapeutics, a clinical-stage biotechnology company developing RNA interference (RNAi) therapies, raised $200 million in an upsized initial public offering, pricing 11.1 million shares...
SKN | TCGX Acquisition Corp. II Files for $100 Million Nasdaq IPO to Pursue a Future Business Combination
TCGX Acquisition Corp. II has filed to raise $100 million through an initial public offering of Class A ordinary shares, seeking to establish a...
SKN | City Therapeutics Raises $200 Million in Upsized IPO as RNAi Drug Development Draws Investor Interest
City Therapeutics, Inc. has priced an upsized initial public offering at $18 per share, targeting approximately $200 million in gross proceeds as the clinical-stage...
SKN | Cleveland-Cliffs Shares Fall 3.42% Ahead of October 19 Earnings Report
Cleveland-Cliffs Inc. (NYSE: CLF) fell 3.42% to $12.15, declining $0.43 from its previous close of $12.58, according to the October 16, 2026, market snapshot....
SKN | HDFC Bank Shares Rise 3.98% as Investors Look Ahead to Quarterly Earnings
HDFC Bank Limited (NYSE: HDB) gained 3.98% to close at $23.53, up $0.90 from its previous close of $22.63, according to the October 16,...